Journal of Clinical Densitometry
Volume 12, Issue 2 , Pages 195-199 , April 2009

Prevalence of Cortical Osteoporosis in Mild and Severe Primary Hyperparathyroidism and its Relationship With Bone Markers and Vitamin D Status

  • Francisco Bandeira

      Affiliations

    • Division of Endocrinology, Agamenon Magalhães Hospital, Brazilian Health Authority, University of Pernambuco, Recife, Brazil
    • Pernambuco Osteoporosis Center, Recife, Brazil
    • Corresponding Author InformationAddress correspondence to: Francisco Bandeira, MD, PhD, FACE, Division of Endocrinology, Agamenon Magalhães Hospital, University of Pernambuco Medical School, Estrada do Arraial 2723, 52051-380, Recife, Brazil.
    • ,
  • Luiz H. Griz

      Affiliations

    • Division of Endocrinology, Agamenon Magalhães Hospital, Brazilian Health Authority, University of Pernambuco, Recife, Brazil
    • Pernambuco Osteoporosis Center, Recife, Brazil
    • ,
  • Cristina Bandeira

      Affiliations

    • Division of Endocrinology, Agamenon Magalhães Hospital, Brazilian Health Authority, University of Pernambuco, Recife, Brazil
    • Pernambuco Osteoporosis Center, Recife, Brazil
    • ,
  • Jorge Pinho

      Affiliations

    • Division of Head and Neck Surgery, Memorial São José Hospital, Recife, Brazil
    • ,
  • Cynthia S. Lucena

      Affiliations

    • Division of Endocrinology, Agamenon Magalhães Hospital, Brazilian Health Authority, University of Pernambuco, Recife, Brazil
    • Pernambuco Osteoporosis Center, Recife, Brazil
    • ,
  • Clineu Alencar

      Affiliations

    • Division of Endocrinology, Agamenon Magalhães Hospital, Brazilian Health Authority, University of Pernambuco, Recife, Brazil
    • Pernambuco Osteoporosis Center, Recife, Brazil
    • ,
  • Ana C. Thé

      Affiliations

    • Division of Endocrinology, Agamenon Magalhães Hospital, Brazilian Health Authority, University of Pernambuco, Recife, Brazil
    • Pernambuco Osteoporosis Center, Recife, Brazil
    • ,
  • Erik T. Diniz

      Affiliations

    • Division of Endocrinology, Agamenon Magalhães Hospital, Brazilian Health Authority, University of Pernambuco, Recife, Brazil
    • Pernambuco Osteoporosis Center, Recife, Brazil

Received 8 April 2008 ,Revised 23 November 2008 ,Accepted 24 November 2008.

References 

  1. Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med. 2005;257:6–17
  2. Ruda JM, Hollenbeak CS, Stack BC Jr. 2005 A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132:359–372.
  3. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302:189–193
  4. Bandeira F. 2004 Treatment of primary hyperparathyroidism. Proc 12th International Congress of Endocrinology, Lisbon, 19.23.
  5. Mithal A, et al. Clinical presentation of primary hyperparathyroidism in Índia, Brazil and China. In:  Bilezikian JP editors. The parathyroids: basic and clinical concepts. San Diego: Academic Press; 2001;375.141
  6. Bandeira F, Caldas G, Freese E, et al. Relationship between serum vitamin D status and clinical manifestations of primary hyperparathyroidism. Endocr Pract. 2002;8:266–270
  7. Bandeira F, Griz L, Dreyer P, et al. Vitamin D deficiency: a global perspective. Arq Bras Endocrinol Metab. 2006;50(4):640–646
  8. Locker F, Parisien M, Dempster D, et al. Vitamin D deficiency may alter the clinical course of primary hyperparathyroidism. J Bone Miner Res. 1997;13(Suppl):S522
  9. Bandeira F, Caldas G, Freese E, et al. Characteristics of primary hyperparathyroidism in one institution in northeast Brazil. Bone. 1998;23:S380
  10. Silverberg SJ, Bilezikian JP. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81:4007–4012
  11. Kulak CA, Bandeira C, Voss D, et al. Marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica. J Clin Endocrinol Metab. 1998;83:732–735
  12. Silverberg SJ, Bilezikian JP, Bone HG, et al. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab. 1999;84:2275–2285
  13. Rosen CJ. Postmenopausal osteoporosis. N Engl J Med. 2005;353:595–603
  14. Hagström E, Lundgren E, Mallmin H, et al. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J Intern Med. 2006;259(2):191–198
  15. De Geronimo S, Romagnoli E, Diacinti D, et al. The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol. 2006;155(3):415–420
  16. Bandeira F, Freese E. Prevalence of osteoporosis and vertebral fractures in postmenopausal women attending reference centers. Rev Bras Epidemiol. 2007;10(1):86–98
  17. Chappard C, Roux C, Laugier P, et al. Bone status in primary hyperparathyroidism assessed by regional bone mineral density from the whole body scan and QUS imaging at calcaneus. Joint Bone Spine. 2006;73(1):86–94
  18. Bandeira F, Griz L, Caldas G, et al. From mild to severe primary hyperparathyroidism: the Brazilian experience. Arq Bras Endocrinol Metab. 2006;50(4):657–663

PII: S1094-6950(08)00505-2

doi: 10.1016/j.jocd.2008.11.005

Journal of Clinical Densitometry
Volume 12, Issue 2 , Pages 195-199 , April 2009

Article Tools

* Image Usage & Resolution